Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, Arcadium Lithium, Richemont
These Stocks Moved the Most Today: Pfizer, Super Micro, Generac, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, and More
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and Apple and Amazon shares are downgraded.
Stocks to Watch Monday: Pfizer, Arcadium Lithium, Richemont
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported](
Why Pfizer Stock Popped on Monday
How Pfizer got itself in a pickle. As the Journal explains, Pfizer bet big on vaccines to protect people from COVID, but as the pandemic waned, so did interest in (and sales of) i
Starboard Takes Stake in Pfizer
Pfizer CEO Bourla To Meet Activist Investor Starboard, Report Says
KEY TAKEAWAYS Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion stake in the struggling drugmaker.Bourla and at least one other director will hold discussions with Starboard next week,
Bloomberg Businessweek: Starboard Takes Stake in Pfizer
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.
As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?
While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030. It said following the deal, it now has eight or more potential blockbuster drugs in its pipeline.
bovnews
2h
The PFE Conundrum: Why Pfizer Inc’s Stock Is Making Headlines Again
On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...
1d
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
2d
Pfizer’s Stock Buy Rating: Undervalued with Growth Potential and Strategic Management Actions
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...
6d
Is Pfizer a Buy Right Now or a Value Trap?
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
2d
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
2d
Pfizer (PFE) Gets a Hold from J.P. Morgan
J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...
1d
Stock Market Today: Dow edges up, Nasdaq rises 1% as stocks rebound from Monday's selloff
The Roundhill Magnificent Seven ETF — which holds Big Tech stocks including Nvidia, Apple Inc., Microsoft Corp, Alphabet Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Starboard Value
Albert Bourla
The Wall Street Journal
Feedback